Non-Hodgkin lymphoma (supportive care)
Also known as: Non-Hodgkin lymphoma, Non-Hodgkin's lymphoma, NHL, B-cell non-Hodgkin lymphoma, T-cell non-Hodgkin lymphoma
Non-Hodgkin lymphoma encompasses diverse lymphoid malignancies requiring subtype-specific haematological assessment and management. Supportive care focuses on mitigating fatigue, nausea, anorexia, insomnia, and psychological distress, but must not replace systemic oncological therapy or surveillance. In this framework, TCM patterns facilitate symptomatic assessment rather than identifying histological subtype, staging, or therapeutic response. Current evidence cited provides no empirical support for acupuncture or herbal medicine in the supportive care of lymphoma. Record 1 investigates mechanistic pathways, record 2 addresses paediatric disease burden, record 3 lacks an abstract, and record 4 concerns unrelated lumbar disc pathology. Any acupuncture intervention requires coordination with the oncology team and individualised safety screening. Herbal references provided represent traditional options only; safety advice is precautionary.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Maintain a concise record of fatigue levels, nausea, sleep quality, nutritional intake, and body temperature for review during oncological consultations.
- •Balance physical activity with scheduled rest periods, adhering to clinical guidance regarding anaemia, skeletal involvement, or treatment-related limitations.
- •Adhere to strict food hygiene protocols and follow dietetic-led nutritional plans; avoid restrictive or unvalidated 'anticancer' diets and unreviewed supplements.
- •Comply with all infection-prevention measures and vaccination schedules as directed by the oncology team; do not modify pharmaceutical regimens or surveillance schedules in favour of complementary interventions.
Cautions & Contraindications
- •Defer needling with fever, suspected infection, active bleeding or clinically significant cytopenias until oncology clearance. Review current counts, anticoagulants and treatment timing rather than applying a universal laboratory threshold. Record 2 supplies supportive-care context only, not acupuncture safety criteria.[]
- •Do not use these traditional formulas as anticancer treatments or infer herbal benefit from CD74/MIF biology. Record 1 identifies a candidate mechanistic target requiring further validation and provides no evidence for the listed formulas or their compatibility with cancer medicines.[]
- •Do not extrapolate the lumbar-disc acupuncture cohort to lymphoma efficacy or safety: its population and outcomes are unrelated, and vertebral malignancy was excluded. Avoid needling over tumour masses, enlarged nodes, infected or irradiated damaged skin, vascular access devices, and areas of lymphoedema; these site precautions were not tested in that cohort.[]
When to reassess or seek care again
Record baseline fatigue and nausea on 0–10 scales, sleep duration, intake, weight trend and patient-selected functional goals. Review after 1–2 weeks or 2–3 sessions, and before each visit check treatment changes, infection symptoms and oncology advice on counts. Stop and refer for deterioration, new neurological symptoms, bleeding or red flags; seek oncology review for persistent poor intake or weight loss. If no meaningful symptom improvement within 2–4 weeks, discontinue or revise the adjunctive approach. Symptom improvement must not be interpreted as lymphoma response.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Translational oncology · 2026
- Jornal de pediatria · 2026
- Indian journal of pediatrics · 2026
- Journal of pain research · 2026
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
